Janssen Announces U.S. FDA Approval of TREMFYA™ (Guselkumab) for the Treatment
Mayo

Janssen Announces U.S. FDA Approval of TREMFYA™ (Guselkumab) for the Treatment

2020 × 2700 px October 12, 2024 Peter Mayo

Janssen Announces U.S. FDA Approval of TREMFYA™ (Guselkumab) for the Treatment is a high-quality image in the Mayo collection, available at 2020 × 2700 pixels resolution — ideal for both digital and print use.

Learn what Tremfya is used for in treating plaque psoriasis and psoriatic arthritis. Discover how this biologic medication works to manage your symptoms.

Image Details

TitleJanssen Announces U.S. FDA Approval of TREMFYA™ (Guselkumab) for the Treatment
Dimensions2020 × 2700 px
CategoryMayo
PublishedOctober 12, 2024
AuthorZeus
Downloads337
Views1,419

Read full article: What Is Tremfya Used For

// More Images